Peter Slover
Patrimonio netto: 51 768 $ in data 31/07/2026
Patrimonio netto: 51 768 $ in data 31/07/2026
Mr. Peter T.
Slover, CPA, is a Chief Financial & Accounting Officer at Contineum Therapeutics, Inc. Mr. Slover was previously employed as a Chief Financial & Accounting Officer by Sophiris Bio, Inc., a Vice President-Finance & Operations by Anadys Pharmaceuticals, Inc., and an Auditor by KPMG LLP.
He received his undergraduate degree from Shippensburg University of Pennsylvania.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/04/2026 | 3.342 ( 0,01% ) | 51 768 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/09/2020 |
| Società | Posizione | Fine |
|---|---|---|
| SOPHIRIS BIO | Direttore Finanziario/CFO | 01/05/2020 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Direttore Finanziario/CFO | - |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 01/01/2004 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Sophiris Bio, Inc.
Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Shippensburg University of Pennsylvania
Shippensburg University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pipeline Therapeutics, Inc.
Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale